United States Securities and Exchange Commission · EDGAR Accession 0002134643-26-000002

Form C

Offering Statement — Regulation Crowdfunding
Issuer CIK 2134643
Raising via StartEngine Primary, LLC

EVOQ Biomed, Inc.

CorporationDEIncorporated 2015Salt Lake City, UTevoqmm.com/solutions/evoq-bio
A

The Offering

as disclosed in this filing
Other (Simple Agreement for Future Equity)
$20,000
$1,235,000
August 31, 2026
78 days remaining
$0max $1,235,000

Target is 2% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenue1 employee
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(2,000)0
Total assets18,0000
Cash & equivalents00
Accounts receivable00
Short-term debt00
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.